I
Ilda B. Molloy
Researcher at Dartmouth–Hitchcock Medical Center
Publications - 17
Citations - 326
Ilda B. Molloy is an academic researcher from Dartmouth–Hitchcock Medical Center. The author has contributed to research in topics: Medicine & Arthroplasty. The author has an hindex of 5, co-authored 15 publications receiving 183 citations. Previous affiliations of Ilda B. Molloy include University of Texas at Austin & The Dartmouth Institute for Health Policy and Clinical Practice.
Papers
More filters
Journal ArticleDOI
Effects of the Length of Stay on the Cost of Total Knee and Total Hip Arthroplasty from 2002 to 2013.
TL;DR: With demographic characteristics showing an upward trend in the utilization of joint arthroplasty, including a shift toward younger population groups, reduction in length of stay remains an important target for procedure-level cost containment under emerging payment models.
Journal ArticleDOI
Guidelines for Patient-Centered Opioid Prescribing and Optimal FDA-Compliant Disposal of Excess Pills after Inpatient Operation: Prospective Clinical Trial
Eleah D. Porter,Sarah Y. Bessen,Ilda B. Molloy,Julia L. Kelly,Niveditta Ramkumar,Niveditta Ramkumar,Joseph D. Phillips,Andrew P. Loehrer,Matthew Z. Wilson,Rian M. Hasson,Srinivas J. Ivatury,Jessica Henkin,Richard J. Barth +12 more
TL;DR: In this article, a clinical trial was conducted to evaluate patient-centered opioid discharge prescription guidelines and increase the FDA-compliant disposal rate of leftover opioid pills to higher than currently reported rates of 20% to 30%.
Journal ArticleDOI
Online Information and Mentorship: Perspectives From Orthopaedic Surgery Residency Applicants.
TL;DR: Both online information and mentorship can be improved to create a more effective application experience if the orthopaedic community fostered better mentorship for applicants, they may not feel compelled to rely on subpar online information.
Journal ArticleDOI
Short term patient outcomes after total knee arthroplasty: Does the implant matter?
Ilda B. Molloy,Benjamin J. Keeney,Benjamin J. Keeney,Michael B. Sparks,Michael B. Sparks,Nicholas G. Paddock,Karl M. Koenig,Wayne E. Moschetti,Wayne E. Moschetti,David S. Jevsevar,David S. Jevsevar +10 more
TL;DR: The data show no difference in physical function and most outcomes between Sigma and Attune, and DePuy PFC Sigma implants had shorter absolute LOS, but there were no differences in extended LOS.
Journal ArticleDOI
Preoperative Patient-Reported Outcomes and Clinical Characteristics as Predictors of 90-Day Cost/Utilization and Complications.
Daniel J. Snyder,Dennis M. Bienstock,Aakash Keswani,Jared C. Tishelman,Amy Ahn,Ilda B. Molloy,Karl M. Koenig,David S. Jevsevar,Jashvant Poeran,Calin S. Moucha +9 more
TL;DR: Low baseline VR- 12 PCS is predictive of high 90-day bundle costs and neither VR-12 nor HOOS/KOOS JR was predictive of 90- day readmission or complications.